Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 479367, 12 pages
http://dx.doi.org/10.1155/2014/479367
Research Article

Lead Screening for HIV-1 Integrase (IN) Inhibited by Traditional Chinese Medicine

1Department of Biomedical Informatics, Asia University, Taichung 41354, Taiwan
2School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan
3Department of Neurosurgery, China Medical University Hospital, No. 2 Yude Road, North District, Taichung 40447, Taiwan
4Department of Anesthesiology, China Medical University Hospital, Taichung 40447, Taiwan
5Research Center for Chinese Medicine and Acupuncture, China Medical University, Taichung 40402, Taiwan

Received 21 February 2014; Accepted 5 March 2014; Published 11 June 2014

Academic Editor: Chung Y. Hsu

Copyright © 2014 Tzu-Chieh Hung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Barre-Sinoussi, J. C. Chermann, F. Rey et al., “Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS),” Science, vol. 220, no. 4599, pp. 868–871, 1983. View at Google Scholar · View at Scopus
  2. M. W. Cloyd, J. J. Y. Chen, and L. Q. Wang, “How does HIV cause AIDS? The homing theory,” Molecular Medicine Today, vol. 6, no. 3, pp. 108–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Weiss, “How does HIV cause AIDS?” Science, vol. 260, no. 5112, pp. 1273–1279, 1993. View at Google Scholar · View at Scopus
  4. D. C. Douek, M. Roederer, and R. A. Koup, “Emerging concepts in the immunopathogenesis of AIDS,” Annual Review of Medicine, vol. 60, pp. 471–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Weller and K. Davis, “Condom effectiveness in reducing heterosexual HIV transmission,” The Cochrane Database of Systematic Reviews, no. 1, Article ID CD003255, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Leynaert, A. M. Downs, and I. de Vincenzi, “Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection,” American Journal of Epidemiology, vol. 148, no. 1, pp. 88–96, 1998. View at Google Scholar · View at Scopus
  7. D. M. Bell, “Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview,” The American Journal of Medicine, vol. 102, no. 5, supplement 2, pp. 9–15, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Cleveland, L. Barker, B. F. Gooch, E. M. Beltrami, and D. Cardo, “Use of HIV postexposure prophylaxis by dental health care personnel: an overview and updated recommendations,” Journal of the American Dental Association, vol. 133, no. 12, pp. 1619–1626, 2002. View at Google Scholar · View at Scopus
  9. J. C. Forbes, A. M. Alimenti, J. Singer et al., “A national review of vertical HIV transmission,” AIDS, vol. 26, no. 6, pp. 757–763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. M. Little, P. H. Kilmarx, A. W. Taylor, C. E. Rose, E. D. Rivadeneira, and S. R. Nesheim, “A review of evidence for transmission of HIV from children to breastfeeding women and implications for prevention,” The Pediatric Infectious Disease Journal, vol. 31, no. 9, pp. 938–942, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Finzi, M. Hermankova, T. Pierson et al., “Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy,” Science, vol. 278, no. 5341, pp. 1295–1300, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Xue, X. Jin, L. Ning, M. Wang, H. Liu, and X. Yao, “Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis,” Journal of Chemical Information and Modeling, vol. 53, no. 1, pp. 210–222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Huang, H. W. Yu, C. Y. Chen et al., “Current developments of computer-aided drug design,” Journal of the Taiwan Institute of Chemical Engineers, vol. 41, no. 6, pp. 623–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. W. I. Tou, S. S. Chang, C. C. Lee, and C. Y. Chen, “Drug design for neuropathic pain regulation from traditional Chinese medicine,” Scientific Reports, vol. 3, article 844, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Y. Chen, “A novel integrated framework and improved methodology of computer-aided drug design,” Current Topics in Medicinal Chemistry, vol. 13, no. 9, pp. 965–988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Y. Chen and W. I. Tou, “How to design a drug for the disordered proteins?” Drug Discovery Today, vol. 18, no. 19-20, pp. 910–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. C. Basak, “Recent developments and future directions at current computer aided drug design,” Current Computer-Aided Drug Design, vol. 9, no. 1, article 1, 2013. View at Google Scholar · View at Scopus
  18. C. Y. Chen, “Weighted equation and rules—a novel concept for evaluating protein-ligand interaction,” Journal of Biomolecular Structure & Dynamics, vol. 27, no. 3, pp. 271–282, 2009. View at Google Scholar · View at Scopus
  19. W.-L. Liao and F.-J. Tsai, “Personalized medicine: a paradigm shift in healthcare,” BioMedicine, vol. 3, no. 2, pp. 66–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. F.-J. Tsai, “Biomedicine brings the future nearer,” BioMedicine, vol. 1, no. 1, article 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. C. Lee, C.-H. Tsai, L. Wan et al., “Increased incidence of Parkinsonism among Chinese with β-glucosidase mutation in central Taiwan,” BioMedicine, vol. 3, no. 2, pp. 92–94, 2013. View at Publisher · View at Google Scholar
  22. W.-Y. Lin, H.-P. Liu, J.-S. Chang et al., “Genetic variations within the PSORS1 region affect Kawasaki disease development and coronary artery aneurysm formation,” BioMedicine, vol. 3, no. 2, pp. 73–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C.-H. Wang, W.-D. Lin, D.-T. Bau, I. Chou, C. Tsai, and F. Tsai, “Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway,” BioMedicine, vol. 3, no. 2, pp. 82–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-M. Chang, B. K. Velmurugan, W.-W. Kuo et al., “Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells,” BioMedicine, vol. 3, no. 4, pp. 148–152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. F.-J. Tsai, “Rare diseases: a mysterious puzzle,” BioMedicine, vol. 3, no. 2, article 65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. I. C. Chou, W.-D. Lin, C.-H. Wang et al., “Möbius syndrome in a male with XX/XY mosaicism,” BioMedicine, vol. 3, no. 2, pp. 102–104, 2013. View at Publisher · View at Google Scholar
  27. Y.-T. Chang, W.-D. Lin, Z.-N. Chin et al., “Nonketotic hyperglycinemia: a case report and brief review,” BioMedicine, vol. 2, no. 2, pp. 80–82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-H. Wang, W.-D. Lin, and F.-J. Tsai, “Craniofacial dysmorphism, what is your diagnosis?” BioMedicine, vol. 2, no. 2, pp. 49–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Y. Chen, “TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H. J. Huang, K. J. Lee, H. W. Yu et al., “Structure-based and ligand-based drug design for HER 2 receptor,” Journal of Biomolecular Structure & Dynamics, vol. 28, no. 1, pp. 23–37, 2010. View at Google Scholar · View at Scopus
  31. W. I. Tou and C. Y. Chen, “Traditional Chinese medicine as dual guardians against hypertension and cancer?” Journal of Biomolecular Structure & Dynamics, vol. 30, no. 3, pp. 299–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. C. Yang, S. S. Chang, and C. Y. Chen, “Identifying HER2 inhibitors from natural products database,” PLoS ONE, vol. 6, no. 12, Article ID e28793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Y. Chen, “Insights into designing the dual-targeted HER2/HSP90 inhibitors,” Journal of Molecular Graphics & Modelling, vol. 29, no. 1, pp. 21–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. K. C. Chen and C. Y. C. Chen, “Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach,” Soft Matter, vol. 7, no. 8, pp. 4001–4008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. C. Yang, S. S. Chang, H. Y. Chen, and C. Y. Chen, “Identification of potent EGFR inhibitors from TCM Database@Taiwan,” PLoS Computational Biology, vol. 7, no. 10, Article ID e1002189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. K. C. Chen, M. F. Sun, S. C. Yang et al., “Investigation into potent inflammation inhibitors from traditional Chinese medicine,” Chemical Biology & Drug Design, vol. 78, no. 4, pp. 679–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. S. Chang, H. J. Huang, and C. Y. Chen, “High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan,” Molecular BioSystems, vol. 7, no. 12, pp. 3366–3374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. H. Lin, T. T. Chang, M. F. Sun et al., “Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database,” Journal of Biomolecular Structure & Dynamics, vol. 28, no. 4, pp. 471–482, 2011. View at Google Scholar · View at Scopus
  39. S. S. Chang, H. J. Huang, and C. Y. Chen, “Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Y. Chen, Y. H. Chang, D. T. Bau et al., “Ligand-based dual target drug design for H1N1: swine flu—a preliminary first study,” Journal of Biomolecular Structure & Dynamics, vol. 27, no. 2, pp. 171–178, 2009. View at Google Scholar · View at Scopus
  41. H. J. Huang, Y. R. Jian, and C. Y. Chen, “Traditional Chinese medicine application in HIV: an in silico study,” Journal of Biomolecular Structure & Dynamics, vol. 32, no. 1, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  42. T. Y. Tsai, K. W. Chang, and C. Y. Chen, “iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 525–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. K. W. Chang, T. Y. Tsai, K. C. Chen et al., “iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design,” Journal of Biomolecular Structure & Dynamics, vol. 29, no. 1, pp. 243–250, 2011. View at Google Scholar · View at Scopus
  44. B. Xue, R. L. Dunbrack, R. W. Williams, A. K. Dunker, and V. N. Uversky, “PONDR-FIT: a meta-predictor of intrinsically disordered amino acids,” Biochimica et Biophysica Acta, vol. 1804, no. 4, pp. 996–1010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. C. M. Venkatachalam, X. Jiang, T. Oldfield, and M. Waldman, “LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites,” Journal of Molecular Graphics & Modelling, vol. 21, no. 4, pp. 289–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. B. R. Brooks, C. L. Brooks III, A. D. Mackerell Jr. et al., “CHARMM: the biomolecular simulation program,” Journal of Computational Chemistry, vol. 30, no. 10, pp. 1545–1614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Cherepanov, A. L. Ambrosio, S. Rahman, T. Ellenberger, and A. Engelman, “Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 48, pp. 17308–17313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. U. Velaparthi, P. Y. Liu, B. Balasubramanian et al., “Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile,” Bioorganic & Medicinal Chemistry Letters, vol. 17, no. 11, pp. 3072–3076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Rogers and A. J. Hopfinger, “Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships,” Journal of Chemical Information and Computer Sciences, vol. 34, no. 4, pp. 854–866, 1994. View at Google Scholar · View at Scopus
  50. Y. Fujikoshi, T. Noguchi, M. Ohtaki, and H. Yanagihara, “Corrected versions of cross-validation criteria for selecting multivariate regression and growth curve models,” Annals of the Institute of Statistical Mathematics, vol. 55, no. 3, pp. 537–553, 2003. View at Google Scholar · View at Scopus
  51. C. Y. C. Chen, “Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5,” Journal of Molecular Graphics & Modelling, vol. 28, no. 3, pp. 261–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. R. E. Fan, P. H. Chen, and C. J. Lin, “Working set selection using second order information for training support vector machines,” Journal of Machine Learning Research, vol. 6, pp. 1889–1918, 2005. View at Google Scholar · View at Scopus
  53. R. A. Laskowski and M. B. Swindells, “LigPlot+: multiple ligand-protein interaction diagrams for drug discovery,” Journal of Chemical Information and Modeling, vol. 51, no. 10, pp. 2778–2786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. C. Wallace, R. A. Laskowski, and J. M. Thornton, “LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions,” Protein Engineering, vol. 8, no. 2, pp. 127–134, 1995. View at Google Scholar · View at Scopus
  55. U. D. Priyakumar and A. D. MacKerell, “Comparison of the CHARMM27, AMBER4.1 and BMS nucleic acid force fields via free energy calculations of base flipping,” Abstracts of Papers of the American Chemical Society, vol. 230, pp. U1391–U1392, 2005. View at Google Scholar
  56. B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl, “GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation,” Journal of Chemical Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. V. Zoete, M. A. Cuendet, A. Grosdidier, and O. Michielin, “SwissParam: a fast force field generation tool for small organic molecules,” Journal of Computational Chemistry, vol. 32, no. 11, pp. 2359–2368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. T. A. Darden and L. G. Pedersen, “Molecular modeling: an experimental tool,” Environmental Health Perspectives, vol. 101, no. 5, pp. 410–412, 1993. View at Google Scholar · View at Scopus
  59. S. A. Lee, S. K. Hong, C. I. Suh et al., “Anti-HIV-1 efficacy of extracts from medicinal plants,” The Journal of Microbiology, vol. 48, no. 2, pp. 249–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Murakami, H. Harada, M. A. Suico et al., “Ephedrae herba, a component of Japanese herbal medicine Mao-to, efficiently activates the replication of latent human immunodeficiency virus type 1 (HIV-1) in a monocytic cell line,” Biological & Pharmaceutical Bulletin, vol. 31, no. 12, pp. 2334–2337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. S. C. Morton, “Statistical collaboration to impact policy decisions,” Statistics in Medicine, vol. 24, no. 4, pp. 493–501, 2005. View at Publisher · View at Google Scholar
  62. R. Chintalova-Dallas, P. Case, N. Kitsenko, and Z. Lazzarini, “Boltushka: a homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine,” The International Journal of Drug Policy, vol. 20, no. 4, pp. 347–351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. R. V. House, P. T. Thomas, and H. N. Bhargava, “Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines,” Immunopharmacology and Immunotoxicology, vol. 16, no. 1, pp. 1–21, 1994. View at Google Scholar · View at Scopus
  64. E. Chovancova, A. Pavelka, P. Benes et al., “CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures,” PLoS Computational Biology, vol. 8, no. 10, Article ID e1002708, 2012. View at Publisher · View at Google Scholar · View at Scopus